Evidence map›Paper›PMID 35929429›Full record

ReviewEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022

Hepatitis of unknown aetiology in children - epidemiological overview of cases reported in Europe, 1 January to 16 June 2022.

Adriana Romaní Vidal, Aisling Vaughan, Francesco Innocenti, Soledad Colombe, Lina Nerlander, Natalia Rachwal, Bruno Christian Ciancio, Aikaterini Mougkou, Carlos Carvalho, Enrique Delgado and 44 more

Abstract readReview
In one paragraph

Review in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Enterovirus infections in children.Pediatric investigation · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Task Force for a rapid response to an outbreak of severe acute hepatitis of unknown aetiology in children in Portugal in 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

54 authors.

Adriana Romaní VidalEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Aisling VaughanWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Francesco InnocentiEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Soledad ColombeWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Lina NerlanderEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Natalia RachwalEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Bruno Christian CiancioEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Aikaterini MougkouEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Carlos CarvalhoEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Enrique DelgadoEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Piers MookWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Géraldine de MuylderSciensano, Epidemiology of Infectious Diseases, Brussels, Belgium.
Michael PeetersSciensano, Infectious Diseases in Humans, Viral Diseases, National Reference Centre for Hepatitis Viruses, Brussels, Belgium.
Tencho TenevNational Reference Laboratory Hepatitis viruses, NCIPD-Virology, Sofia, Bulgaria.
Elitsa Golkocheva-MarkovaNational Reference Laboratory Hepatitis viruses, NCIPD-Virology, Sofia, Bulgaria.
Veronika Vorobieva Solholm JensenDepartment of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
Anders KochInfectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
Julie FigoniSanté Publique France, the National Public Health Agency, Saint-Maurice, France.
Cécile BrouardSanté Publique France, the National Public Health Agency, Saint-Maurice, France.
Georgia NikolopoulouGreek National Public Health Organization (EODY), Athens, Greece.
Anastasia ZisouliGreek National Public Health Organization (EODY), Athens, Greece.
Niamh MurphyHealth Service Executive HPSC surveillance scientist on the National IMT for hepatitis, Dublin, Ireland.
Annemarie BroderickChildren's Health Ireland (CHI), Crumlin, Ireland.
Lital GoldbergIsrael Ministry of Health, Jerusalem, Israel.
Rivka RichIsrael Ministry of Health, Jerusalem, Israel.
Lior Hecht SagieIsrael Ministry of Health, Jerusalem, Israel.
Maria Elena TostiNational Centre for Global Health - Istituto Superiore di Sanità, Rome, Italy.
Barbara SuligoiInfectious Disease Department - Istituto Superiore di Sanità, Rome, Italy.
Rosa JoostenNational Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, the Netherlands.
Roan PijnackerNational Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Bilthoven, the Netherlands.
Ingvild FjeldheimDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Eli HeenDepartment of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway.
Małgorzata StępieńDepartment of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.
Piotr PolańskiDepartment of Epidemiology of Infectious Diseases and Surveillance, National Institute of Public Health NIH - National Research Institute, Warsaw, Poland.
Rui Tato MarinhoGastroenterology and Hepatology Department, Hospital S. Maria; Medical School of Lisbon; National Programme for Viral Hepatitis, Portugal Ministry of Health, Lisbon, Portugal.
João Vieira MartinsDirectorate of Information and Analysis, Directorate-General of Health, Lisbon, Portugal.
Carmen VarelaNational Centre of Epidemiology, Carlos III Institute of Health, CIBERESP, Madrid, Spain.
Ana AvellónNational Centre of Microbiology, Carlos III Institute of Health, CIBERESP, Madrid, Spain.
Emmi AnderssonPublic Health Agency of Sweden, Solna, Sweden.
Marie Jansson MörkPublic Health Agency of Sweden, Solna, Sweden.
Sema MandalUnited Kingdom Health Security Agency Epidemiology Cell, London, United Kingdom.
Conall WatsonUnited Kingdom Health Security Agency Epidemiology Cell, London, United Kingdom.
Laura CoughlanUnited Kingdom Health Security Agency Epidemiology Cell, London, United Kingdom.
Meera ChandUnited Kingdom Health Security Agency Incident Director, London, United Kingdom.
Claire NeillPublic Health Agency Northern Ireland, Belfast, United Kingdom.
Declan T BradleyPublic Health Agency Northern Ireland, Belfast, United Kingdom.
Kathy LiRegional Virology Laboratory Belfast Health and Social Care Trust, Northern Ireland, Belfast, United Kingdom.
Maureen O'LearyClinical and Protecting Health Directorate, Public Health Scotland, Glasgow, United Kingdom.
Neil McInnesWest of Scotland Specialist Virology Centre, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.
Christopher J WilliamsPublic Health Wales, Cardiff, United Kingdom.
Catherine MoorePublic Health Wales, Cardiff, United Kingdom.
Ardiana GjiniPublic Health Wales, Cardiff, United Kingdom.
Erika DuffellEuropean Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
Richard PebodyWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Following the report of an excess in paediatric cases of severe acute hepatitis of unknown aetiology by the United Kingdom (UK) on 5 April 2022, 427 cases were reported from 20 countries in the World Health Organization European Region to the European Surveillance System TESSy from 1 January 2022 to 16 June 2022. Here, we analysed demographic, epidemiological, clinical and microbiological data available in TESSy. Of the reported cases, 77.3% were 5 years or younger and 53.5% had a positive test for adenovirus, 10.4% had a positive RT-PCR for SARS-CoV-2 and 10.3% were coinfected with both pathogens. Cases with adenovirus infections were significantly more likely to be admitted to intensive care or high-dependency units (OR = 2.11; 95% CI: 1.18-3.74) and transplanted (OR = 3.36; 95% CI: 1.19-9.55) than cases with a negative test result for adenovirus, but this was no longer observed when looking at this association separately between the UK and other countries. Aetiological studies are needed to ascertain if adenovirus plays a role in this possible emergence of hepatitis cases in children and, if confirmed, the mechanisms that could be involved.

Indexed as

COVID-19Hepatitis AChildEuropeHospitalizationHumansSARS-CoV-2adenovirushepatitispaediatric acute liver failure, EuropeTESSyunknown aetiologyWHO European Region

Identifiers

PMID35929429
PMCPMC9358403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.